Nexalin Technology, Inc. Current Liabilities
Nexalin Technology, Inc. (NXL) had Current Liabilities of $1.48 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Liabilities, Current $1.48M.
- 2026-03-31: Liabilities, Current $808.36K.
- 2025-12-31: Liabilities, Current $887.33K.
- 2025-09-30: Liabilities, Current $357.52K.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $1.48M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $808.36K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $887.33K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $357.52K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $600.58K 10-Q · filed 2025-08-06 |
| 2025-03-31 | $574.74K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $546.69K 10-K · filed 2026-03-25 |
| 2024-09-30 | $299.39K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $212.10K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $507.22K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $425.28K 10-K/A · filed 2025-09-23 |
| 2023-09-30 | $1.20M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.18M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $1.20M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $1.95M 10-K · filed 2024-03-27 |
| 2022-09-30 | $1.98M 10-Q · filed 2022-11-10 |
| 2021-12-31 | $2.36M 10-K · filed 2023-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |